Development of digoxin dry elixir as a novel dosage form using a spray-drying technique
- 1 January 1995
- journal article
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 12 (5) , 547-556
- https://doi.org/10.3109/02652049509006785
Abstract
A rapidly absorbed new novel oral dosage form for digoxin termed ‘digoxin dry elixir’ was developed by the spray-drying technique. Digoxin, dextrin and sodium lauryl sulphate were dissolved in a ethanol-water mixture (20:25 w/w) and therefore spray-dried to form the digoxin dry elixir. According to scanning electron micrographs, digoxin dry elixir is spherical in shape with a smooth surface. The geometric mean diameter of dry elixir determined by laser particle size analysis was about 13 pm. The appearance and flow properties were almost unchanged and about 10% of ethanol contents in the dry elixir decreased during 180 days in a sealed bottle at room temperature. Comparative studies on the in vitro dissolution and in vivo absorption of digoxin in the form of digoxin dry elixir, digoxin elixir and digoxin powder were carried out. Digoxin in the dry elixirs was completely dissolved within 2 min. On the other hand, only about 87% of digoxin powder dissolved in 60min. The initial dissolution rates of digoxin in the dry elixirs markedly increased in distilled water at 37°C, which were over 100 fold higher than that of digoxin powder alone. The maximal plasma concentration of digoxin (Cmax) and area under the digoxin concentration-time curve from zero to 6h (AUC0–6h) after the oral administration of digoxin dry elixir were almost 3.8 and 5.5 fold increased compared to digoxin powder alone. No significant difference of AUC0–6h between dry elixir and elixir was observed, but the Cmax of digoxin in the form of dry elixir was significantly reduced compared to the digoxin elixir (0.57 versus 0.83). Digoxin dry elixir might be a useful solid dosage form to improve the dissolution rate and bioavailability of poorly water-soluble digoxin compared to digoxin powder alone. It also indicates that dry elixir might reduce the side effects in oral digitalis glycoside therapy compared to the digoxin elixir due to the reduction of Cmax.Keywords
This publication has 10 references indexed in Scilit:
- Preparation and evaluation of a dry elixir for the enhancement of the dissolution rate of poorly water-soluble drugsInternational Journal of Pharmaceutics, 1994
- Improvement of the Oral Bioavailability of Digitalis Glycosides by CyclodextrinComplexationJournal of Pharmaceutical Sciences, 1983
- PharmacokineticsPublished by Taylor & Francis ,1982
- Differential Thermal, Solubility, and aging Studies on various Sources of Digoxin and Digitoxin Powder: Biopharmaceutical ImplicationsJournal of Pharmaceutical Sciences, 1979
- Kinetics of Digoxin Stability in Aqueous SolutionJournal of Pharmaceutical Sciences, 1978
- Bioavailability and Dissolution Properties of two Commercial Digoxin TabletsJournal of Pharmaceutical Sciences, 1974
- Rapidly Dissolving Forms of Digoxin: Hydroquinone ComplexJournal of Pharmaceutical Sciences, 1974
- Influence of Dispersion Method on Dissolution Rate of Digoxin–Lactose and Hydrocortisone–Lactose Triturations IJournal of Pharmaceutical Sciences, 1974
- Increased Dissolution Rates of Water-Insoluble Cardiac Glycosides and Steroids via Solid Dispersions in Polyethylene Glycol 6000Journal of Pharmaceutical Sciences, 1971
- Diffusion coefficients of water and organic volatiles in carbohydrate‐water systemsInternational Journal of Food Science & Technology, 1970